Lasa Supergenerics Q3FY21 PAT at 6.56 Crores up by 154 per cent YoY Finance Cost Reduced by 95.40 per cent YoY
Feb 02, 2021
Mumbai (Maharashtra) [India], February 02 (ANI/NewsVoir): Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial results for the third quarter ended December 31, 2020 (Q3FY21).